Nanoparticle-Mediated Delivery of Anticancer Agents to Tumor Angiogenic Vessels

Author:

Asai Tomohiro1

Affiliation:

1. Department of Medical Biochemistry, Graduate Division of Pharmaceutical Sciences, University of Shizuoka

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Reference18 articles.

1. 2) Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW, Langer R, Jacks T, Anderson DG. Treating metastatic cancer with nanotechnology. Nat. Rev. Cancer, 12, 39–50 (2012).

2. 3) Burnett JC, Rossi JJ, Tiemann K. Current progress of siRNA/shRNA therapeutics in clinical trials. Biotechnol. J., 6, 1130–1146 (2011).

3. 4) Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res., 46, 6387–6392 (1986).

4. Enhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application

5. 7) Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat. Rev. Drug Discov., 6, 273–286 (2007).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3